Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer

Introduction: Advanced non-small cell lung cancer (NSCLC) is traditionally treated with platinum-based chemotherapy and radiotherapy. Since immunotherapy holds promise for treating advanced NSCLC, we assessed the systemic effects of the traditional therapies for NSCLC on immune cell composition and...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebian Yazdi, Mehrdad, Schinkelshoek, Mink S., Loof, Nikki M., Taube, Christian, Hiemstra, Pieter S., Welters, Marij J. P., van der Burg, Sjoerd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214754/
https://www.ncbi.nlm.nih.gov/pubmed/28123900
http://dx.doi.org/10.1080/2162402X.2016.1255393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214754/
https://www.ncbi.nlm.nih.gov/pubmed/28123900
http://dx.doi.org/10.1080/2162402X.2016.1255393

Ejemplares similares